Could a chemo drug boost immunotherapy for tough cancers?
NCT ID NCT05276284
First seen Jan 15, 2026 · Last updated May 09, 2026 · Updated 15 times
Summary
This study tested whether adding a chemotherapy-like drug (thiopurine) to an immunotherapy (Atezolizumab) could help shrink advanced solid tumors that have spread. 18 adults with metastatic cancer that had no standard cure took part. The goal was to find the safest dose and see if the combination could slow or stop tumor growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Copenhagen, Rigshospitalet
Copenhagen, 2100, Denmark
Conditions
Explore the condition pages connected to this study.